Medclair AB (NGM:MCLR)
Sweden · Delayed Price · Currency is SEK 2.960
-0.100 (-3.27%)
At close: Sep 3, 2026
Medclair AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 54.13 | 56.07 | 35.95 | 42.42 | 28.17 | 13.32 | |
Revenue Growth | 30.73% | 55.96% | -15.25% | 50.60% | 111.49% | 107.70% |
Cost of Revenue | 19.27 | 18.02 | 12.6 | 17.66 | 7.76 | 5.8 |
Gross Profit | 34.86 | 38.04 | 23.35 | 24.76 | 20.41 | 7.52 |
Selling, General & Admin | 31.95 | 27.39 | 24.31 | 21.91 | 19 | 15.32 |
Other Operating Expenses | -4.23 | -0.05 | -0.08 | -0.05 | - | -0.09 |
Operating Expenses | 32.72 | 32.34 | 29.51 | 27.39 | 24.38 | 20.34 |
Operating Income | 2.14 | 5.7 | -6.17 | -2.63 | -3.97 | -12.82 |
Interest Expense | -0.2 | -0.59 | -0.23 | -0.37 | -0.08 | -0.11 |
Interest & Investment Income | 0.1 | 0.1 | 0.19 | 0.2 | - | - |
Currency Exchange Gain (Loss) | -1.03 | -1.03 | -0.57 | -0.83 | -0.37 | -0.09 |
Other Non Operating Income (Expenses) | - | - | - | -0 | - | - |
EBT Excluding Unusual Items | 1.01 | 4.19 | -6.76 | -3.63 | -4.42 | -13.01 |
Gain (Loss) on Sale of Assets | 0.47 | 0.47 | 6.1 | 0.85 | -0.57 | - |
Pretax Income | 1.48 | 4.65 | -0.66 | -2.78 | -4.99 | -13.01 |
Income Tax Expense | - | - | - | 0.01 | 0.01 | 0.01 |
Net Income | 1.48 | 4.65 | -0.66 | -2.79 | -5 | -13.02 |
Net Income to Common | 1.48 | 4.65 | -0.66 | -2.79 | -5 | -13.02 |
Net Income Growth | -27.07% | - | - | - | - | - |
Shares Outstanding (Basic) | - | 78 | 66 | 93 | 83 | 81 |
Shares Outstanding (Diluted) | - | 78 | 66 | 93 | 83 | 81 |
Shares Change | - | 16.79% | -28.47% | 11.40% | 2.41% | - |
EPS (Basic) | - | 0.06 | -0.01 | -0.03 | -0.06 | -0.16 |
EPS (Diluted) | - | 0.06 | -0.01 | -0.03 | -0.06 | -0.16 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.35 | 6.91 | 1.19 | 4.23 | -11.77 | -8.68 |
Free Cash Flow Per Share | - | 0.09 | 0.02 | 0.05 | -0.14 | -0.11 |
Gross Margin | 64.40% | 67.85% | 64.94% | 58.38% | 72.46% | 56.45% |
Operating Margin | 3.96% | 10.17% | -17.16% | -6.20% | -14.09% | -96.25% |
Profit Margin | 2.73% | 8.30% | -1.85% | -6.57% | -17.75% | -97.76% |
Free Cash Flow Margin | 2.48% | 12.32% | 3.31% | 9.97% | -41.79% | -65.16% |
EBITDA | 6.94 | 10.41 | -1.49 | 1.88 | 0.12 | -8.85 |
EBITDA Margin | 12.82% | 18.57% | -4.16% | 4.44% | 0.41% | -66.44% |
D&A For EBITDA | 4.8 | 4.71 | 4.67 | 4.52 | 4.09 | 3.97 |
EBIT | 2.14 | 5.7 | -6.17 | -2.63 | -3.97 | -12.82 |
EBIT Margin | 3.96% | 10.17% | -17.16% | -6.20% | -14.09% | -96.25% |
Revenue as Reported | 56.58 | 56.58 | 36.71 | 43.32 | 28.44 | 13.41 |